These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33419096)

  • 1. Genetic and Antigenetic Characterization of the Novel Kotalahti Bat Lyssavirus (KBLV).
    Calvelage S; Tammiranta N; Nokireki T; Gadd T; Eggerbauer E; Zaeck LM; Potratz M; Wylezich C; Höper D; Müller T; Finke S; Freuling CM
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33419096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus.
    Shipley R; Wright E; Lean FZX; Selden D; Horton DL; Fooks AR; Banyard AC
    Viruses; 2021 May; 13(5):. PubMed ID: 34065574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe.
    Servat A; Wasniewski M; Cliquet F
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31614675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel bat lyssavirus in a Long-fingered bat (Myotis capaccinii) from Slovenia.
    Černe D; Hostnik P; Toplak I; Presetnik P; Maurer-Wernig J; Kuhar U
    PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011420. PubMed ID: 37384601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies on the genetic, antigenic and pathogenic characteristics of Bokeloh bat lyssavirus.
    Nolden T; Banyard AC; Finke S; Fooks AR; Hanke D; Höper D; Horton DL; Mettenleiter TC; Müller T; Teifke JP; Freuling CM
    J Gen Virol; 2014 Aug; 95(Pt 8):1647-1653. PubMed ID: 24828330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species.
    Malerczyk C; Freuling C; Gniel D; Giesen A; Selhorst T; Müller T
    Hum Vaccin Immunother; 2014; 10(10):2799-804. PubMed ID: 25483634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses.
    Weir DL; Coggins SA; Vu BK; Coertse J; Yan L; Smith IL; Laing ED; Markotter W; Broder CC; Schaefer BC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33804519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tentative novel lyssavirus in a bat in Finland.
    Nokireki T; Tammiranta N; Kokkonen UM; Kantala T; Gadd T
    Transbound Emerg Dis; 2018 Jun; 65(3):593-596. PubMed ID: 29446230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2.
    Nokireki T; Jakava-Viljanen M; Virtala AM; Sihvonen L
    Acta Vet Scand; 2017 Oct; 59(1):64. PubMed ID: 28969696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses.
    Evans JS; Wu G; Selden D; Buczkowski H; Thorne L; Fooks AR; Banyard AC
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29543715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pathogenesis of different phylogroup I bat lyssaviruses in a standardized mouse model.
    Klein A; Eggerbauer E; Potratz M; Zaeck LM; Calvelage S; Finke S; Müller T; Freuling CM
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009845. PubMed ID: 35041652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus.
    Shipley R; Wright E; Smith SP; Selden D; Fooks AR; Banyard AC
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favourable outcome in a patient bitten by a rabid bat infected with the European bat lyssavirus-1.
    Van Gucht S; Verlinde R; Colyn J; Vanderpas J; Vanhoof R; Roels S; Francart A; Brochier B; Suin V
    Acta Clin Belg; 2013; 68(1):54-8. PubMed ID: 23627196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation, antigenicity and immunogenicity of Lleida bat lyssavirus.
    Banyard AC; Selden D; Wu G; Thorne L; Jennings D; Marston D; Finke S; Freuling CM; Müller T; Echevarría JE; Fooks AR
    J Gen Virol; 2018 Dec; 99(12):1590-1599. PubMed ID: 29745870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective Enhanced Bat Lyssavirus Surveillance in Germany between 2018-2020.
    Klein A; Calvelage S; Schlottau K; Hoffmann B; Eggerbauer E; Müller T; Freuling CM
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses.
    Evans JS; Selden D; Wu G; Wright E; Horton DL; Fooks AR; Banyard AC
    J Gen Virol; 2018 Feb; 99(2):169-180. PubMed ID: 29300155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe.
    Echevarría JE; Banyard AC; McElhinney LM; Fooks AR
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31554170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnostics for the detection of Bokeloh bat lyssavirus in a bat from Bavaria, Germany.
    Freuling CM; Abendroth B; Beer M; Fischer M; Hanke D; Hoffmann B; Höper D; Just F; Mettenleiter TC; Schatz J; Müller T
    Virus Res; 2013 Nov; 177(2):201-4. PubMed ID: 23932899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2.
    Müller T; Selhorst T; Burow J; Schameitat A; Vos A
    Dev Biol (Basel); 2006; 125():195-204. PubMed ID: 16878477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary trends of European bat lyssavirus type 2 including genetic characterization of Finnish strains of human and bat origin 24 years apart.
    Jakava-Viljanen M; Nokireki T; Sironen T; Vapalahti O; Sihvonen L; Huovilainen A
    Arch Virol; 2015 Jun; 160(6):1489-98. PubMed ID: 25877913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.